Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSX:TIH
TSX:TIHTrade Distributors

Is It Too Late To Consider Toromont Industries (TSX:TIH) After Its 63% One-Year Rally

If you are wondering whether Toromont Industries is fairly priced or stretched at its current level, this article will walk you through what the numbers are saying about the stock. Toromont’s share price recently closed at C$197.33, alongside returns of 8.9% over 7 days, 15.1% over 30 days, 17.6% year to date, 63.1% over 1 year, 85.5% over 3 years and 130.9% over 5 years. This naturally raises questions about value and risk. Recent coverage has focused on Toromont’s role in capital goods and...
TSX:BN
TSX:BNCapital Markets

Brookfield (TSX:BN) Margin Improvement And One Off Loss Test Rich 128x P/E Narrative

Brookfield (TSX:BN) has put fresh numbers on the table for FY 2025, with Q3 revenue of US$19.5b and basic EPS of US$0.08, alongside trailing 12 month revenue of US$76.9b and EPS of US$0.37. Together these figures frame the latest quarter within a fuller earnings picture. Over recent quarters the company has seen revenue move from US$20.9b in Q3 2024 to US$19.5b in Q3 2025, while quarterly EPS shifted from US$0.01 to US$0.08 and trailing 12 month EPS moved from US$0.39 in Q2 2024 to US$0.37 in...
TSE:4502
TSE:4502Pharmaceuticals

Takeda Pharmaceutical’s Valuation After FDA Priority Review And New AI Drug Discovery Collaboration

Takeda Pharmaceutical (TSE:4502) just cleared two meaningful milestones, with the U.S. FDA granting Priority Review for its narcolepsy type 1 candidate oveporexton and a new AI-focused drug discovery collaboration with Iambic. See our latest analysis for Takeda Pharmaceutical. The recent regulatory progress for oveporexton and the AI drug discovery partnership with Iambic come as Takeda’s shares trade at ¥5,609, with a 30-day share price return of 11.73%, a 90-day share price return of...
SWX:ALC
SWX:ALCMedical Equipment

Assessing Alcon (SWX:ALC) Valuation As Analyst Interest Follows PRECISION7 Launch In Canada

Analyst attention and new product launch put Alcon in focus Alcon (SWX:ALC) has come into the spotlight after RBC Capital and BTIG reiterated positive views and William Blair began coverage, shortly after the company announced its PRECISION7 weekly replacement contact lenses in Canada. See our latest analysis for Alcon. Despite the recent analyst attention and the PRECISION7 launch, Alcon’s 1 year total shareholder return decline of 25.77% and 5 year total shareholder return decline of 4.19%...
NasdaqGS:CNDT
NasdaqGS:CNDTProfessional Services

Conduent (CNDT) Loss-Making Quarter Extends On US$767 Million Revenue Challenging Margin Improvement Narratives

Conduent (CNDT) has just posted its FY 2025 third quarter numbers, with revenue of US$767 million and a net income loss of US$48 million, translating to basic EPS of a US$0.31 loss. Over recent quarters the company has seen revenue move from US$828 million and EPS of US$1.09 in Q2 2024 to US$751 million and EPS of a US$0.33 loss in Q1 2025, before landing at US$767 million and EPS of a US$0.31 loss in Q3 2025. Trailing twelve month figures now sit at US$3.1 billion of revenue and an EPS loss...
NYSE:PSX
NYSE:PSXOil and Gas

Assessing Phillips 66 (PSX) Valuation After Recent Share Price Momentum

Why Phillips 66 (PSX) is on investors’ radar Phillips 66 (PSX) has drawn fresh attention after recent share price moves, with the stock showing mixed short term returns but stronger performance over the past month and past 3 months. See our latest analysis for Phillips 66. The recent 1 day share price decline of 3.24% to US$156.26 sits against a stronger trend, with a 30 day share price return of 13.48% and a 1 year total shareholder return of 29.14%. Together these figures suggest momentum...
NasdaqGS:RIVN
NasdaqGS:RIVNAuto

Rivian Class Action Settlement And What It Means For Valuation Risks

Rivian Automotive (NasdaqGS:RIVN) has agreed to a proposed $250 million settlement of a securities class action lawsuit. The case concerns investors who bought Rivian stock in the period following its IPO. The proposed settlement is subject to court approval, with a hearing scheduled for May 2026. Rivian Automotive, trading at around $14.0, has seen mixed share price performance, with a 2.0% return over the past week and a 25.7% decline over the past month. Year to date, the stock shows a...
NYSE:NOW
NYSE:NOWSoftware

ServiceNow AI Deals Expand Workflow Reach While Shares Trade Below Targets

ServiceNow (NYSE:NOW) and consulting firm Kearney announced a new AI partnership to help enterprises automate and redesign core business processes using the ServiceNow AI Platform. Bearing introduced a physical security operations solution built directly on ServiceNow, expanding the platform into security operations for physical sites. These announcements highlight new AI driven workflow and security use cases for ServiceNow across large organizations. For investors watching how large...
SEHK:2419
SEHK:2419Food

A Look At Dekon Food and Agriculture Group (SEHK:2419) Valuation After Recent Governance And Accounting Changes

Why Dekon’s latest governance moves matter for shareholders Dekon Food and Agriculture Group (SEHK:2419) has just reshaped its governance framework, with shareholders backing a new independent director, refreshed board committees, China Accounting Standards and a new auditor at the recent extraordinary general meeting. For you as an investor, this package of changes puts board oversight, audit quality and disclosure practices in sharper focus. This can influence how you think about risk,...
NasdaqGS:SNEX
NasdaqGS:SNEXCapital Markets

StoneX Group’s Record Trading Activity Reframes Growth And Valuation Debate

StoneX Group reported record activity in listed derivatives and precious metals trading, supported by its global logistics network and business structure. The company is progressing with the integration of R.J. O'Brien, following the acquisition, and is pushing into new commercial and environmental markets. These operational shifts are reshaping how StoneX Group, NasdaqGS:SNEX, competes across trading and risk management services. For investors watching NasdaqGS:SNEX, the operational news...
NYSE:CTRE
NYSE:CTREHealth Care REITs

A Look At CareTrust REIT’s (CTRE) Valuation After Strong Results And 2026 Growth Outlook

CareTrust REIT (CTRE) drew investor attention after reporting fourth quarter and full year results that exceeded revenue expectations, alongside higher funds from operations and fresh guidance for 2026. See our latest analysis for CareTrust REIT. The recent update on higher funds from operations and 2026 guidance comes after a strong run in the shares, with a 30 day share price return of 7.44% and a 1 year total shareholder return of 57.78%. This suggests momentum has been building rather...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

UPLIZNA’s Expanded EU Use in Autoimmune Disease Could Be A Game Changer For Amgen (AMGN)

Amgen recently reported that the European Commission approved UPLIZNA (inebilizumab) as an add-on therapy for adults with generalized myasthenia gravis who are anti-acetylcholine receptor or anti-muscle specific tyrosine kinase antibody positive, expanding the drug’s use alongside its prior approvals in neuromyelitis optica spectrum disorder and immunoglobulin G4-related disease. This decision strengthens Amgen’s presence in rare autoimmune conditions, adding a twice-yearly maintenance...
NYSE:UPS
NYSE:UPSLogistics

Is It Time To Reassess United Parcel Service (UPS) After Recent Share Price Rebound

If you are wondering whether United Parcel Service shares are offering fair value at around US$118, you are not alone. This article is designed to help you size up what you are really paying for. The stock has returned 1.3% over the last 7 days, 10.8% over the last 30 days, 16.9% year to date, 9.1% over 1 year, while the 3 year and 5 year returns sit at 25.9% and 10.5% declines. Recent attention on UPS has been shaped by broader debates around parcel volumes, cost inflation and how the...
NYSE:TMHC
NYSE:TMHCConsumer Durables

A Look At Taylor Morrison Home (TMHC) Valuation After Q4 Beat And Expanded Buyback Program

Taylor Morrison Home (TMHC) is back in focus after Q4 2025 results topped Wall Street forecasts on both revenue and earnings, supported by firm demand in higher priced communities and an expanded share buyback plan. See our latest analysis for Taylor Morrison Home. The latest Q4 beat and expanded buyback come after a 90 day share price return of 9.61% and a three year total shareholder return of 80.71%. This suggests momentum has built steadily over time despite some near term volatility. If...
NYSE:SJM
NYSE:SJMFood

A Look At J. M. Smucker (SJM) Valuation After Major Executive Leadership Restructuring

J. M. Smucker (SJM) just reshaped its leadership structure, removing the chief operating officer role and expanding responsibilities for several senior executives. This move could meaningfully influence how investors think about the stock. See our latest analysis for J. M. Smucker. The leadership reshuffle comes after a strong recent run, with a 30 day share price return of 9.25% and a year to date share price return of 14.88%, in contrast to a 15.83% decline in total shareholder return over...